Evidence map›Paper›PMID 37103976›Full record

ArticleHuman vaccines & immunotherapeutics2023

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China.

Yi-Hua Zhou, Jinhong Yu, Lu Zhou, Biyun Xu, Yudong Dai, Haining Wang, Wensan Zhou, Hong Zhao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Yi-Hua ZhouDepartments of Laboratory Medicine and of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Jinhong YuDepartment of Transfusion Medicine, Second Hospital of Nanjing, Southeast University, Nanjing, Jiangsu, China.
Lu ZhouDepartments of Laboratory Medicine and of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Biyun XuMedical Statistics and Analysis Center, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Yudong DaiBlood Supply Department, Nanjing Red Cross Blood Center, Nanjing, Jiangsu, China.
Haining WangBlood Supply Department, Nanjing Red Cross Blood Center, Nanjing, Jiangsu, China.
Wensan ZhouDepartments of Laboratory Medicine and of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Hong ZhaoDepartment of Infectious Diseases, Second Hospital of Nanjing, Southeast University, Nanjing, Jiangsu, China.
Beijing Red Cross Blood Center · CNNanjing Second Hospital · CNNanjing University · CNNanjing Drum Tower Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Universal infant hepatitis B vaccination has been implemented more than three decades. This study aimed to determine the prevalence of antibodies to hepatitis B surface antigen (anti-HBs) and to hepatitis B core antigen (anti-HBc) in qualified blood donors in Nanjing, China. Plasmas of 815 qualified blood donors, collected from February through May 2019, were measured for anti-HBs and anti-HBc by enzyme-linked immunosorbent assay. There were 449 (55.1%) male and 366 (44.9%) female blood donors, with a median age of 28.9 years (18-60). The seroprevalence of anti-HBs was 58.8%, with no significant difference in different genders and different age groups. The overall prevalence of anti-HBc was 7.0%, with an increasing trend with age, from 0% in 18-20 years old group to 17.9% in 51-60 years old group (

Indexed as

Hepatitis BHepatitis B Surface AntigensAdolescentAdultBlood DonorsChinaFemaleHepatitis B AntibodiesHepatitis B Core AntigensHepatitis B virusHumansInfantMaleMiddle AgedPrevalenceSeroepidemiologic StudiesHepatitis B AntibodiesHepatitis B Core AntigensHepatitis B Surface Antigensantibody to hepatitis B core antigenantibody to hepatitis B surface antigenprevalenceQualified blood donors

Identifiers

PMID37103976
PMCPMC10142315
OpenAlexW4367174566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.